Clinical Trials Logo

Gynecologic Cancer clinical trials

View clinical trials related to Gynecologic Cancer.

Filter by:

NCT ID: NCT06278610 Recruiting - Gynecologic Cancer Clinical Trials

Pelvic Exenteration and Laterally Extended Pelvic Resection

Pre-PEX
Start date: November 19, 2020
Phase:
Study type: Observational

Growing evidence in literature is supporting the role of ultrasound scan (US) as accurate tool in diagnosis and staging of gynecologic cancers. In particular, different studies demonstrated the accuracy of US in assessing endometrial, cervical, and ovarian cancer in the primary setting. However, the number of studies investigating the role of US in the recurrent setting is limited. Moreover, there is no evidence in literature exploring the role of US in laterally-extended pelvic recurrences from gynecologic cancer, where the Magnetic Resonance Imaging (MRI) scan is still considered the most accurate tool.

NCT ID: NCT06253182 Recruiting - Breast Cancer Clinical Trials

Psychosexual Educational Partners Program (PEPP)

PEPP
Start date: February 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to compare two Psychosexual Educational programs for women who have completed treatment for breast or gynecological cancer and their partners in preparation for a well-powered phase III study. The investigators plan to enroll 30 dyads in a 2-arm pilot randomized controlled trial (RCT). The primary aim will be to assess the preliminary efficacy of the Psychosexual Educational Partners Program (PEPP) on sexual communication.

NCT ID: NCT06216002 Recruiting - Frailty Clinical Trials

Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery

FIGO
Start date: January 2, 2024
Phase: N/A
Study type: Interventional

Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.

NCT ID: NCT06215950 Recruiting - Ovarian Cancer Clinical Trials

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer

Start date: January 10, 2024
Phase: Phase 1
Study type: Interventional

This is a single-center, double-arm, open-label study. this study plans to evaluate the safety and efficacy of CD70-targeting CAR-T cells in the treatment of CD70-positive advanced/metastatic Gynecologic Cancer, and obtain recommended doses and infusion patterns.

NCT ID: NCT06204354 Not yet recruiting - Gynecologic Cancer Clinical Trials

Construction of Gynecological Tumor Sample Library

Start date: January 2024
Phase:
Study type: Observational

Constructing a gynecological tumor samples library, which is open and can be accessed.

NCT ID: NCT06200948 Recruiting - Lymphedema Clinical Trials

Effects of Aerobic Cycling Training in Patients With Gynecologic Cancer-related Lower Extremity Lymphedema

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

Comparison of complete decongestive treatment and complete decongestive treatment + cycling ergometry treatment in patients with gynecologic cancer-related lower extremity lymphedema in terms of quality of life, lower extremity functionality and lower extremity volume measurement

NCT ID: NCT06176274 Not yet recruiting - Gynecologic Cancer Clinical Trials

Pre-Operative Prehabilitation Program Women With Gynecological Cancer

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of the prehabilitation program applied to postmenopausal women diagnosed with gynecological cancer before surgery on postoperative recovery, planned as a randomized study with an experimental design with a pre-test post-test control group.

NCT ID: NCT06168825 Active, not recruiting - Breast Cancer Clinical Trials

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention

MOM
Start date: January 17, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this study is to learn if the Mind Over Matter (MOM) Intervention, a 5-week group program, can help Black and African American women deal with the fears, worries and sadness that often accompany cancer diagnosis and treatment. The main question this study aims to answer is: • Whether the MOM Intervention is feasible and acceptable among Black and African American women. We would also like to find out if: - The MOM Intervention decreases anxiety, depression and physical symptom severity for Black and African American women. - The MOM Intervention is culturally and linguistically appropriate, and identify barriers, strengths, and areas of improvement. Participants will: - Attend a Pre-Program Orientation - Attend 5 weekly MOM Sessions - Complete 2 questionnaires (one will be given before the first MOM Session begins, and the other will be given after the last MOM Session) Participants also have the choice to attend an optional Focus Group, which will be offered after the last MOM Session. Please note, this entire Intervention will be offered online. There will be no in-person sessions or visits.

NCT ID: NCT06155370 Not yet recruiting - Gynecologic Cancer Clinical Trials

Construction of Gynecological Tumor Organoids

Start date: December 1, 2023
Phase:
Study type: Observational

This study focuses on the construction of a biological sample library for organoids and tumor tissues in gynecological tumors.

NCT ID: NCT06139458 Recruiting - Gynecologic Cancer Clinical Trials

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

Start date: January 18, 2024
Phase: N/A
Study type: Interventional

The investigators aim to determine the effect of cryotherapy wraps plus compression therapy (henceforth referred to as cryocompression) versus cryotherapy wraps alone on the incidence and degree of chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer using a noninferiority design. The investigators also aim to determine the effect of cryocompression versus cryotherapy on patient tolerability and patient and staff satisfaction.